Cargando…

In silico identification of novel PKC βII inhibitors: ligand and receptor based pharmacophore modeling, virtual screening, and molecular dynamics study

Detalles Bibliográficos
Autores principales:	Grewal, Baljinder K, Sobhia, ME
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341299/ http://dx.doi.org/10.1186/1758-2946-4-S1-P45

Ejemplares similares

Virtual screening and in silico design of novel inhibitors of bacterial lectins
por: Alán, Jan, et al.
Publicado: (2012)

Virtual screening workflow for glycogen synthase kinase 3β inhibitors: convergence of ligand-based and structure-based approaches
por: Palyulin, VA, et al.
Publicado: (2011)

pharmACOphore: multiple flexible ligand alignment based on ant colony optimization
por: Hessler, Gerhard, et al.
Publicado: (2010)

Ligand-Based Pharmacophore Modeling and Virtual Screening for the Discovery of Novel 17β-Hydroxysteroid Dehydrogenase 2 Inhibitors
por: Vuorinen, Anna, et al.
Publicado: (2014)

Pharmacophore and Virtual Screening of JAK3 inhibitors
por: Rajeswari, Murugesan, et al.
Publicado: (2014)

Topological pharmacophores: pros & cons of QSARs based on 2D pharmacophore fingerprints
por: Horvath, D
Publicado: (2008)

Ligand Based Pharmacophore Modeling and Virtual Screening Studies to Design Novel HDAC2 Inhibitors
por: Kandakatla, Naresh, et al.
Publicado: (2014)

Exploring benchmark dataset bias in ligand based virtual screening
por: Baumann, Knut, et al.
Publicado: (2008)

Identification of Novel HIV 1- Protease Inhibitors: Application of Ligand and Structure Based Pharmacophore Mapping and Virtual Screening
por: Yadav, Divya, et al.
Publicado: (2012)

Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques
por: Al-Balas, Qosay A., et al.
Publicado: (2013)

Evaluation of different machine learning methods for ligand-based virtual screening
por: Kurczab, R, et al.
Publicado: (2011)

Using structure- and Ligand-based pharmacophores as filters to discriminate Human Aryl Sulfotransferase 1A1 (SUL1A1) binders into substrates and inhibitors
por: Soliman, Salwa M, et al.
Publicado: (2014)

A 3D-QSAR model for cannabinoid receptor (CB2) ligands derived from aligned pharmacophors
por: Günther, Robert, et al.
Publicado: (2013)

Selective ligands of estrogen receptor β discovered using pharmacophore mapping and structure-based virtual screening
por: Chen, Lei, et al.
Publicado: (2014)

In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches
por: Sahayarayan, Jesudass Joseph, et al.
Publicado: (2021)

Assessment of a probabilistic framework for combining structure- and ligand-based virtual screening
por: Fulle, Simone, et al.
Publicado: (2012)

Identification of SUMO activating enzyme 1 inhibitors utilizing virtual screening approach
por: Kumar, Ashutosh, et al.
Publicado: (2014)

Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands
por: Alamri, Mubarak A, et al.
Publicado: (2019)

Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors
por: Pal, Sourav, et al.
Publicado: (2019)

Pharmacophore annotation using extended Hückel theory
por: Labute, Paul, et al.
Publicado: (2014)

Use of large multiconformational databases with structure-based pharmacophore models for fast screening of commercial compound collections
por: Del Rio, A, et al.
Publicado: (2011)

In Silico Exploration of Novel Tubulin Inhibitors: A Combination of Docking and Molecular Dynamics Simulations, Pharmacophore Modeling, and Virtual Screening
por: Hadizadeh, Farzin, et al.
Publicado: (2022)

Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches
por: Shinde, Ranajit Nivrutti, et al.
Publicado: (2018)

Kernel learning for ligand-based virtual screening: discovery of a new PPARγ agonist
por: Rupp, Matthias, et al.
Publicado: (2010)

3D pharmacophore alignments: does improved geometric accuracy affect virtual screening performance?
por: Wolber, Gerhard, et al.
Publicado: (2010)

Discovery of YopE Inhibitors by Pharmacophore-Based Virtual Screening and Docking
por: Ozbuyukkaya, Gizem, et al.
Publicado: (2013)

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
por: Kirstgen, Michael, et al.
Publicado: (2021)

Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening Study
por: Galati, Salvatore, et al.
Publicado: (2022)

Tautomerism in structure-based 3D pharmacophore modeling
por: Seidel, Thomas, et al.
Publicado: (2008)

Pharmacophore modeling, docking and molecular dynamics simulation for identification of novel human protein kinase C beta (PKCβ) inhibitors
por: Starosyla, Sergiy A., et al.
Publicado: (2022)

Docking and virtual screening of novel inhibitors for mono-ADP-ribosylating toxins
por: Scharfe, M, et al.
Publicado: (2011)

In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies
por: Meetei, Potshangbam Angamba, et al.
Publicado: (2016)

Design of dual ligands using excessive pharmacophore query alignment
por: Moser, Daniel, et al.
Publicado: (2012)

Automatic pharmacophore model generation using weighted substructure assignments
por: Jahn, Andreas, et al.
Publicado: (2010)

Cavka – a new automatic pharmacophore elucidation method in progress
por: Koelling, F, et al.
Publicado: (2011)

Brute-force pharmacophore assessment and scoring with Open3DQSAR
por: Tosco, P, et al.
Publicado: (2011)

Drug Design by Pharmacophore and Virtual Screening Approach
por: Giordano, Deborah, et al.
Publicado: (2022)

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
por: Jang, Cheongyun, et al.
Publicado: (2018)

Identification of Novel Mitochondrial Pyruvate Carrier Inhibitors by Homology Modeling and Pharmacophore-Based Virtual Screening
por: Hegazy, Lamees, et al.
Publicado: (2022)

Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
por: Kaserer, Teresa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fqdjkqdtgl2dq8mg881u0euedk